Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.

@article{Reitsamer2003SentinelLN,
  title={Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.},
  author={Roland Reitsamer and Florentia Peintinger and Lukas Rettenbacher and Eva Prokop},
  journal={Journal of surgical oncology},
  year={2003},
  volume={84 2},
  pages={
          63-7
        }
}
BACKGROUND AND OBJECTIVES Sentinel lymph node biopsy (SLNB) is an accurate method for axillary staging in patients with early breast cancer. The aim of this study was to evaluate the accuracy and the feasibility of SLNB in breast cancer patients who had received preoperative (neoadjuvant) chemotherapy. METHODS Patients with advanced breast cancer stage II or III who were treated with neoadjuvant chemotherapy were included in the study. Sentinel lymph node (SLN) identification and biopsy was… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 33 CITATIONS

Le ganglion sentinelle post chimiothérapie

VIEW 15 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress.

  • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2016